1. Home
  2. HLNE vs KRYS Comparison

HLNE vs KRYS Comparison

Compare HLNE & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Lane Incorporated

HLNE

Hamilton Lane Incorporated

HOLD

Current Price

$149.39

Market Cap

6.7B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$287.59

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLNE
KRYS
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.3B
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
HLNE
KRYS
Price
$149.39
$287.59
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$164.33
$250.50
AVG Volume (30 Days)
450.9K
291.8K
Earning Date
02-03-2026
02-18-2026
Dividend Yield
1.42%
N/A
EPS Growth
19.80
275.72
EPS
5.55
6.66
Revenue
$733,070,000.00
$373,164,000.00
Revenue This Year
$8.60
$36.14
Revenue Next Year
$20.69
$42.38
P/E Ratio
$27.43
$43.40
Revenue Growth
13.01
54.51
52 Week Low
$111.98
$122.80
52 Week High
$179.19
$295.98

Technical Indicators

Market Signals
Indicator
HLNE
KRYS
Relative Strength Index (RSI) 58.93 69.92
Support Level $148.94 $271.52
Resistance Level $155.59 $295.98
Average True Range (ATR) 4.93 12.18
MACD -0.09 1.22
Stochastic Oscillator 65.38 87.66

Price Performance

Historical Comparison
HLNE
KRYS

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: